Newly published research in JAMA presents an alternative: a nasal swab test that researchers say accurately diagnoses a child’s asthma subtype. Researchers used the new tests in three studies of ...

Find Nasal Spray Child stock video, 4K footage, and other HD footage from iStock. Get higher quality Nasal Spray Child content, for less—All of our 4K video clips are the same price as HD. Video Back ...

Choose from Nasal Spray Child stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant ... in 3 parents reported that their child has dealt with dental problems ...

A NEW nasal swab has been found to diagnose asthma ... Prof Celedón said: "These tests allow us to presume whether a child has T2-high disease or not. "But they are not 100 per cent accurate ...

Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato, to be used as a standalone treatment for people with severe depression who haven't ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...